Psychedelics as pharmacotherapeutics for substance use disorders: A scoping review on clinical trials and perspectives on underlying neurobiology

Documenti analoghi

• Psychedelic research, assisted therapy and the role of the anaesthetist: A review and insights for experimental and clinical practices
  di: Gisela Lima, et al.
  Pubblicazione: (2024)
• Evaluation of preclinical antipsychotic models used to support first‐in‐human clinical trials
  di: Thi Viet Ha Nguyen, et al.
  Pubblicazione: (2025)
• A scoping review of thresholds for responder and time‐to‐event analysis of patient‐reported outcomes in breast cancer trials
  di: Anna Margarete Maria Thurner, et al.
  Pubblicazione: (2025)
• Exploring new avenues: Psychedelic‐assisted therapy for young people
  di: Ioanna Artemis Vamvakopoulou, et al.
  Pubblicazione: (2026)
• A scoping review of disease‐modifying antirheumatic drug nonadherence in rheumatoid arthritis: Measurement, prevalence and implications for clinical practice
  di: Lauren Fraser, et al.
  Pubblicazione: (2025)